(Q39800533)

14 September 2017

Decreased GABA and glutamate concentration in rat brain after treatment with 6-aminonicotinamide (English)

1 reference

8 May 2022

1 reference

8 May 2022

author name string

L. Bielicki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A138093

8 May 2022

J. Krieglstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A138093

8 May 2022

language of work or name

1 reference

1 August 1976

1 reference

full work available at URL

14 September 2017

http://link.springer.com/content/pdf/10.1007/BF00507848.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00507848/fulltext.html

8 May 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00507848

8 May 2022

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

8 May 2022

published in

1 reference

14 September 2017

294

1 reference

14 September 2017

157-160

1 reference

14 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00507848

14 September 2017

0 references

cites work

6-Aminonicotinamide--a Potent Nicotinamide Antagonist

1 reference

12 December 2020

Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods

1 reference

12 December 2020

[Brain carbohydrate metabolism following blockade of the pentose phosphate pathway by 6-aminonicotinamide]

1 reference

12 December 2020

BIOSYNTHESIS AND EFFECT OF 6-AMINONICOTINAMIDE-ADENINE DINUCLEOTIDE (6-ANAD)

1 reference

12 December 2020

Inhibition of NADP dependent oxidoreductases by the 6-aminonicotinamide analogue of NADP.

1 reference

12 December 2020

6-Aminonicotinamide and acute degenerative changes in the central nervous system

1 reference

12 December 2020

Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide

1 reference

12 December 2020

Morphological findings in the central nervous system of the rat after poisoning with antimetabolites of nicotinamide (6-aminonicotinamide and 3-acetylpyridine) and a quinoline derivative (5-nitro-8-hydroxyquinoline)

1 reference

12 December 2020

[Experimental myelopathy--biochemical basis of its cellular pathogenesis (author's transl)].

1 reference

12 December 2020

Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide

1 reference

12 December 2020

Brain disorders induced by pharmacological blockade of the pentose phosphate pathway.

1 reference

12 December 2020

Behaviour of the glycolytic system of rat brain and kidney in vivo after in hibition of the glucosephosphate isomerase. II. Substrate concentrations under the influence of ischemia, 6-aminonicotinamide, and 2-deoxyglucose.

1 reference

12 December 2020

Inhibition of glucose phosphorylation in rat brain by thiopental

1 reference

12 December 2020

Cerebral energy reserves and glycolysis in neural tissue of 6-aminonicotinamide-treated mice.

1 reference

12 December 2020

The effects of an antimetabolite, 6-amino-nicotinamide, on the central nervous system

1 reference

12 December 2020

Suitability of the isolated perfused rat brain for studying effects on cerebral metabolism.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00507848

1 reference

14 September 2017

1 reference